托西利祖马布在耐火性一般化肌痛性肌痛症患者的疗效和安全性
Zhe Ruan1, Yonglan Tang1, Ting Gao1
1Department of Neurology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
CNS neuroscience & therapeutics
|June 19, 2024
概括
与传统治疗相比,托西利祖马布显著改善了耐火性泛性肌痛性肌痛症 (gMG) 患者的日常生活得分. 这种治疗证明了对乙胆受体抗体阳性 (AChR-Ab+) gMG的安全和有效配置.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一般化肌痛性肌痛症 (gMG) 是一种影响神经肌肉结合的自身免疫性疾病.
- 耐火性ACHR-Ab+gMG患者通常具有有限的治疗选择.
- 将托西利祖马布与传统免疫疗法进行比较对于耐火性GMG管理至关重要.
研究的目的:
- 为了比较托西利祖马布与常规免疫治疗在耐火性ACHR-Ab+gMG患者中的疗效.
- 评估对日常生活活动和整体疾病严重程度的影响.
- 评估tocilizumab在这个患者群体中的安全性和耐受性.
主要方法:
- 一个单一中心前性队列研究,涉及34名耐火ACHR-Ab+gMG患者.
- 患者被分配到托西利祖马布或常规免疫疗法组.
- 主要结局是24周内MG日常生活活动 (MG-ADL) 评分的变化,使用通用估计方程模型进行分析.
主要成果:
- 托西利祖马布在第4周显著减少了MG-ADL得分,持续到第24周.
- 在接受托西利祖马布治疗的患者中,更高比例的患者在24周内在MG-ADL和QMG得分上取得了显著的改善.
- 托西利祖马布表现出可接受的安全性,没有严重或意外的不良事件.
结论:
- 托西利祖马布是一种安全有效的治疗方法,用于改善耐火性ACHR-Ab+gMG的MG-ADL得分.
- 该药物显示出作为耐火性gMG患者有价值的治疗选择的潜力.
- 托西利祖马布 (tocilizumab) 可能有助于减少对普得尼松 (prednisone) 的需要,以控制这种情况.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Myasthenia Gravis: Diagnostic Tests
764
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
764
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130
Disorders of the Skeletal Muscle
928
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
928
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Skeletal Muscle Relaxants: Adverse Effects
354
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
354
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

